MLPFX
Price
$11.21
Change
+$0.01 (+0.09%)
Updated
Sep 11 closing price
Net Assets
2.46B
TMLPX
Price
$11.00
Change
-$0.01 (-0.09%)
Updated
Sep 11 closing price
Net Assets
161.01M
Interact to see
Advertisement

MLPFX vs TMLPX

MLPFX vs TMLPX Comparison Chart in %
View a ticker or compare two or three
VS
MLPFX vs. TMLPX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPFX is a Hold and TMLPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPFX has more cash in the bank: 2.46B vs. TMLPX (161M). MLPFX pays higher dividends than TMLPX: MLPFX (5.09) vs TMLPX (3.26). MLPFX was incepted earlier than TMLPX: MLPFX (16 years) vs TMLPX (13 years). MLPFX (1.45) is less costly to investors than TMLPX (1.29). TMLPX is a more actively managed with annual turnover of: 53.00 vs. MLPFX (14.00). MLPFX has a lower initial minimum investment than TMLPX: MLPFX (1000) vs TMLPX (1000000). MLPFX annual gain was more profitable for investors over the last year : 33.03 vs. TMLPX (29.36). MLPFX return over 5 years is better than : 190.95 vs. TMLPX (111.20).
MLPFXTMLPXMLPFX / TMLPX
Total Expense Ratio1.441.29112%
Annual Report Gross Expense Ratio1.451.29112%
Fund Existence16 years13 years-
Gain YTD29.60728.659103%
Front Load6%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.46B161M1,530%
Annual Yield % from dividends5.093.26156%
Returns for 1 year33.0329.36112%
Returns for 3 years97.2289.41109%
Returns for 5 years190.95111.20172%
Returns for 10 years169.23102.24166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKK83.580.52
+0.63%
ARK Innovation ETF
BAMO34.820.20
+0.59%
Brookstone Opportunities ETF
AVK12.230.07
+0.58%
Advent Convertible and Income Fund
AVMU43.780.16
+0.37%
Avantis Core Municipal Fixed Inc ETF
THNR25.59-0.41
-1.59%
Amplify Weight Loss Drug & Treatment ETF